Related Experiment Video
Updated: Jun 18, 2026

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells
1Department of Haematology, Hadassah Hebrew University Medical Centre, Jerusalem, Israel.
Insights
Clinically relevant iron chelators effectively reduce labile iron pool (LIP) and oxidative stress in beta-thalassaemia red blood cells (RBCs) and their precursors. These findings suggest potential therapeutic benefits for improving ineffective erythropoiesis and RBC survival.
Area of Science:
- Hematology
- Redox Biology
- Pharmacology
Background:
- Beta-thalassaemia is characterized by iron accumulation in organs and red blood cells (RBCs), leading to cellular damage via labile iron pool (LIP) and reactive oxygen species (ROS).
- Thalassaemic RBCs and erythroid precursors exhibit elevated LIP and ROS compared to normal counterparts.
- Iron-mediated oxidative stress is a key factor in the pathophysiology of beta-thalassaemia.
Purpose of the Study:
- To investigate the effects of clinically relevant iron chelators on LIP and oxidative stress parameters in beta-thalassaemia.
- To compare the efficacy and kinetics of deferiprone, deferasirox, and deferoxamine in reducing LIP and ROS.
Main Methods:
- Flow cytometry was used to analyze LIP and oxidative stress markers in RBCs, reticulocytes, and cultured erythroid precursors from beta-thalassaemia patients.
- In vitro treatment with deferiprone, deferasirox, and deferoxamine was performed.
Main Results:
- All three chelators (deferiprone, deferasirox, deferoxamine) significantly reduced cytosolic LIP in RBCs and reticulocytes.
- Cytosolic and mitochondrial LIP in cultured erythroid precursors were also reduced by the chelators.
- Reduced oxidative stress (ROS and external phosphatidylserine exposure) was observed following chelation therapy.
- Deferiprone and deferasirox demonstrated rapid effects within 10 minutes, while deferoxamine showed a slower onset of action (24 hours).
Conclusions:
- The studied iron chelators effectively decrease LIP and oxidative stress in thalassaemic RBCs and their precursors.
- The differential kinetics suggest varying cellular uptake or mechanisms of action among the chelators.
- Further research is needed to determine if these reductions in LIP and oxidative stress translate to improved ineffective erythropoiesis and RBC survival in beta-thalassaemia.
Background/Aims:
Iron accumulation in vital organs such as heart and liver is a major pathology in beta-thalassaemia. It may also affect mature RBCs and developing erythroid precursors. The cellular damage is mainly caused by the labile iron pool (LIP) and is mediated by reactive oxygen species (ROS). We have previously shown that thalassaemic RBCs and their precursors have more LIP and ROS than their normal counterparts. We now report the effect of clinically relevant iron chelators on these parameters.
Methods:
RBCs, reticulocytes and cultured erythroid precursors derived from patients with beta-thalassaemia were studied for LIP and oxidative stress parameters by flow-cytometry.
Results:
In vitro treatment with deferiprone, deferasirox and deferoxamine reduced the cytosolic LIP in RBCs and reticulocytes, and both the cytosolic and mitochondrial LIP in cultured erythroid precursors. This was associated with reduced oxidative stress (ROS and external phosphatidylserine). While the effect of deferiprone and deferasirox was fast (within 10 min), deferoxamine affected these parameters after 24 h, suggesting a slower rate of entry.
Conclusion:
The chelators studied reduce the LIP and the oxidative status of thalassaemic RBC and their precursors. Whether these effects directly improve ineffective erythropoiesis and RBC survival remains to be shown.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
Published on: May 4, 2020
05:08Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Related Concept Videos
Antiprotozoal Agents
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Microbes and Other Elemental Cycles
Extraction: Advanced Methods
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
EDTA: Auxiliary Complexing Reagents